Cargando…
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
BACKGROUND: Little is known on factors predicting sunitinib toxicity. Recently, the condition of low muscle mass, named sarcopenia, was identified as a significant predictor of toxicity in metastatic renal cell cancer (mRCC) patients treated with sorafenib. We investigated whether sarcopenia could p...
Autores principales: | Huillard, O, Mir, O, Peyromaure, M, Tlemsani, C, Giroux, J, Boudou-Rouquette, P, Ropert, S, Delongchamps, N Barry, Zerbib, M, Goldwasser, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619075/ https://www.ncbi.nlm.nih.gov/pubmed/23462722 http://dx.doi.org/10.1038/bjc.2013.58 |
Ejemplares similares
-
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
por: Mir, Olivier, et al.
Publicado: (2012) -
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
por: Barth, Claire, et al.
Publicado: (2020) -
Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial
por: Barry Delongchamps, Nicolas, et al.
Publicado: (2021) -
Giant Primary Scrotal Lipoma: A Rare Entity with Diagnostic Pitfalls
por: Vignot, Louis, et al.
Publicado: (2020) -
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab
por: Noel, Johanna, et al.
Publicado: (2022)